Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Nov 15, 2010
Finance
RX+DX gambit
...payments from collaborations. Investors include Perseus-Soros (19.2% pre-IPO stake); Apposite Capital (13.3%); Forward Ventures (11.9%);
Roche Finance
...
Read More
BioCentury
|
Mar 13, 2000
Finance
Changing of the guard
...in Iceland to create and operate a national medical and genetic database(see BioCentury, Jan. 31).
Roche Finance
...
Read More
BioCentury
|
Jun 30, 1997
Finance
A week to forget
...valuation. HealthCare Investment Corp. will own 23 percent of the company post-deal, while Warner-Lambert and
Roche Finance
...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Nov 15, 2010
Finance
RX+DX gambit
...payments from collaborations. Investors include Perseus-Soros (19.2% pre-IPO stake); Apposite Capital (13.3%); Forward Ventures (11.9%);
Roche Finance
...
Read More
BioCentury
|
Mar 13, 2000
Finance
Changing of the guard
...in Iceland to create and operate a national medical and genetic database(see BioCentury, Jan. 31).
Roche Finance
...
Read More
BioCentury
|
Jun 30, 1997
Finance
A week to forget
...valuation. HealthCare Investment Corp. will own 23 percent of the company post-deal, while Warner-Lambert and
Roche Finance
...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page